<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00071110</url>
  </required_header>
  <id_info>
    <org_study_id>R21AT001218-01A1</org_study_id>
    <nct_id>NCT00071110</nct_id>
  </id_info>
  <brief_title>Electroacupuncture for Major Depression</brief_title>
  <official_title>Electroacupuncture for Major Depression: A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Center for Complementary and Integrative Health (NCCIH)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Center for Complementary and Integrative Health (NCCIH)</source>
  <brief_summary>
    <textblock>
      This study will compare the safety, efficacy, and tolerability of electroacupuncture (EA) and
      sham electroacupuncture (SA) for the treatment of major depression.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Major depression is a common and serious mental illness. It is associated with a markedly
      lower quality of life, significant functional impairment, and premature death due to suicide
      or comorbid physical illness. Over the past 50 years, effective and safe treatments for major
      depression have been developed, including antidepressant pharmacotherapy, psychotherapy, and
      electroconvulsive therapy. However, many Americans who suffer from a depressive disorder
      either do not elect to receive one of these conventional treatments or do not complete an
      adequate course of treatment. A growing number of Americans with depression are choosing to
      be treated with complementary and alternative therapies. Acupuncture, in particular, is
      increasingly being used to treat depression even though only limited data support its safety
      and efficacy.

      This study will use a randomized parallel-group design to compare the safety, efficacy, and
      tolerability of electroacupuncture (EA) and sham electroacupuncture (SA) for the treatment of
      major depression. Over a 15-month period, 60 adult outpatients with a major depressive
      disorder of mild or moderate severity (as defined by the DSM-IV) will be randomized to either
      12 sessions of EA or SA to be provided over 6 weeks. Safety and symptomatic improvement (as
      measured with the Hamilton Rating Scale for Depression [HRSD]) will constitute the primary
      outcome measures. Tolerability and functional improvement will constitute secondary outcome
      measures.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2004</start_date>
  <completion_date type="Actual">May 2007</completion_date>
  <primary_completion_date type="Actual">May 2007</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Antidepressant Response, Defined as a Hamilton Depression Rating Scale Score Relative Decrease of 50 % or More and a Final Score &lt; 10</measure>
    <time_frame>Change from Baseline to Post-Intervention Endpoint</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Functioning and Health-related Quality of Life as Rated by the Medical Outcomes Survey-Version 1 (MOS-36) Physical Component Score (MOSPCS)</measure>
    <time_frame>Mean Change from Baseline to Post-Intervention Endpoint</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Functioning and Health-related Quality of Life as Rated by the Medical Outcomes Survey-Version 1 (MOS-36) Mental Component Score (MOSMCS)</measure>
    <time_frame>Mean Change from Baseline to Post-Intervention Endpoint</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Functioning and Health-related Quality of Life as Rated by the Medical Outcomes Survey-Version 1 (MOS-36) Bodily Pain Index (MOSBPI)</measure>
    <time_frame>Mean Change from Baseline to Post-Intervention Endpoint</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">57</enrollment>
  <condition>Depression</condition>
  <condition>Depressive Disorder</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Electroacupuncture (EA).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Sham</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Electroacupuncture</intervention_name>
    <description>For subjects randomized to EA, needles were placed at points GV-20—on the crown of the head and yin tang—on the midline of the forehead roughly at the glabella and treated with electrical stimulation. 30 mm x 0.22 mm sterile stainless steel needles were placed obliquely to a depth of approximately 10 mm and were connected to face-microelectrodes which were connected to the Pantheon Research PENS-Electrostimulator. Electricity was provided at a frequency of 2 Hz and set to a voltage which resulted in the perception of a mild intensity stimulation.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sham</intervention_name>
    <description>For subjects randomized to SA, two needles were placed laterally on the scalp, 3 cuns superior to the temporal attachment of the helix of the ear. This point was selected as it does not correspond to any specific meridian acupuncture point. A disabled electrical cable was connected to the needles and the electrostimulator, with light blinking at 2 Hz but no electrical stimulation provided.</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Meet SCID criteria for a Major Depressive Disorder (Single or Recurrent) with a
             current major depressive episode of mild or moderate severity

          -  Significant symptoms of depression (HRSD &gt; 14)

          -  Ability to communicate in English

          -  Give informed consent in accordance with local IRB regulations

        Exclusion Criteria:

          -  Personal physician's recommendation against enrollment because the patient is
             physically unstable or for other reasons

          -  Having been treated with acupuncture for any condition

          -  History of seizure disorder or significant risk factors for a seizure disorder (e.g.,
             history of brain trauma, recent stroke, or brain tumor)

          -  Need to remain on antidepressant or other psychotropic medications

          -  Absence of depressive symptoms severe enough (i.e., HRSD &lt; 14) at the baseline
             assessments

          -  Significant cognitive impairment, as assessed by a total score on the MMSE &lt; 25. A
             recommendation for referral to a neurologist or a psychiatrist will be made to the
             patient in these cases.

          -  Chronic major depression (i.e, duration of 2 years or longer) A recommendation for
             referral to a psychiatrist will be made in these cases.

          -  Major depressive episode severe or severe with psychotic features (as per DSM-IV/SCID)
             or with acutely suicidality. A recommendation for psychiatric referral will be made in
             these cases. Bipolar disorder, psychotic features, or a psychotic disorder
             (specifically: schizophrenia, delusional disorder, or schizoaffective disorder). A
             recommendation for psychiatric referral will be made in these cases.

          -  Met criteria for a diagnosis of alcohol substance abuse or dependence within the past
             six months. A recommendation for referral to a mental health professional will be made
             in these cases.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benoit H Mulsant, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UPMC Shadyside, Center for Complementary Medicine</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 10, 2003</study_first_submitted>
  <study_first_submitted_qc>October 14, 2003</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 15, 2003</study_first_posted>
  <results_first_submitted>March 27, 2009</results_first_submitted>
  <results_first_submitted_qc>December 4, 2009</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 11, 2010</results_first_posted>
  <last_update_submitted>December 4, 2009</last_update_submitted>
  <last_update_submitted_qc>December 4, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 11, 2010</last_update_posted>
  <keyword>Acupuncture</keyword>
  <keyword>Electroacupuncture</keyword>
  <keyword>Alternative therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>57 Participants were recruited from March 2004 - May 2007 at the UPMC Shadyside Center for Complementary Medicine.</recruitment_details>
      <pre_assignment_details>Twenty-nine subjects were randomized to Sham and 28 to Electroacupuncture.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Electroacupuncture (EA)</title>
          <description>Needles placed at traditional meridian locations, GV-20 (on the crown of the head) and yin tang (in the midline of the forehead roughly at the glabella) and treated with electrical stimulation.</description>
        </group>
        <group group_id="P2">
          <title>Sham Acupuncture (SA)</title>
          <description>Needles placed laterally on the scalp, not corresponding to any traditional meridians. No electrical stimulation delivered.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="28"/>
                <participants group_id="P2" count="29"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="28"/>
                <participants group_id="P2" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Electroacupuncture (EA)</title>
          <description>Needles placed at traditional meridian locations, GV-20 (on the crown of the head) and yin tang (in the midline of the forehead roughly at the glabella) and treated with electrical stimulation.</description>
        </group>
        <group group_id="B2">
          <title>Sham Acupuncture (SA)</title>
          <description>Needles placed laterally on the scalp, not corresponding to any traditional meridians. No electrical stimulation delivered.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="28"/>
            <count group_id="B2" value="29"/>
            <count group_id="B3" value="57"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="53.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="4.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46.04" spread="11.32"/>
                    <measurement group_id="B2" value="48.86" spread="13.12"/>
                    <measurement group_id="B3" value="47.47" spread="12.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="39.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="18.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="57.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Antidepressant Response, Defined as a Hamilton Depression Rating Scale Score Relative Decrease of 50 % or More and a Final Score &lt; 10</title>
        <description>Number of participants whose Hamilton Depression Rating Scale score decreased at least 50% and had a final score less than 10. Minimum score = 0 (best). Maximum score = 52 (worst). The 17 item scale assesses depression symptoms, including Depressed Mood, Feelings of Guilt, Suicidal Ideation, Insomnia, Anxiety, Weight Change, and Insight.</description>
        <time_frame>Change from Baseline to Post-Intervention Endpoint</time_frame>
        <population>ITT, excluding the first four sham acupuncture subjects, whom the primary acupuncturist erred in treating. Although he correctly used the sham electricity procedure, for these subjects he placed needles in the verum electroacupuncture points of GV-20 and Yin tang.</population>
        <group_list>
          <group group_id="O1">
            <title>Electroacupuncture (EA)</title>
            <description>Needles placed at traditional meridian locations, GV-20 (on the crown of the head) and yin tang (in the midline of the forehead roughly at the glabella) and treated with electrical stimulation.</description>
          </group>
          <group group_id="O2">
            <title>Sham Acupuncture (SA)</title>
            <description>Needles placed laterally on the scalp, not corresponding to any traditional meridians. No electrical stimulation delivered.</description>
          </group>
        </group_list>
        <measure>
          <title>Antidepressant Response, Defined as a Hamilton Depression Rating Scale Score Relative Decrease of 50 % or More and a Final Score &lt; 10</title>
          <description>Number of participants whose Hamilton Depression Rating Scale score decreased at least 50% and had a final score less than 10. Minimum score = 0 (best). Maximum score = 52 (worst). The 17 item scale assesses depression symptoms, including Depressed Mood, Feelings of Guilt, Suicidal Ideation, Insomnia, Anxiety, Weight Change, and Insight.</description>
          <population>ITT, excluding the first four sham acupuncture subjects, whom the primary acupuncturist erred in treating. Although he correctly used the sham electricity procedure, for these subjects he placed needles in the verum electroacupuncture points of GV-20 and Yin tang.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Functioning and Health-related Quality of Life as Rated by the Medical Outcomes Survey-Version 1 (MOS-36) Physical Component Score (MOSPCS)</title>
        <description>Mean change in scores on the Medical Outcomes Survey-Version 1 (MOS-36) PHYSICAL Component Score (MOSPCS) from baseline to post-intervention across treatment group. Minimum Score = 0 (worse); Maximum Score = 100 (better), Normed to be at 50 on a control population. Positive Mean Change scores indicate improvement (an increase in scale score/better).</description>
        <time_frame>Mean Change from Baseline to Post-Intervention Endpoint</time_frame>
        <population>ITT, excluding the first four sham acupuncture subjects, whom the primary acupuncturist erred in treating. Although he correctly used the sham electricity procedure, for these subjects he placed needles in the verum electroacupuncture points of GV-20 and Yin tang.</population>
        <group_list>
          <group group_id="O1">
            <title>Electroacupuncture (EA)</title>
            <description>Needles placed at traditional meridian locations, GV-20 (on the crown of the head) and yin tang (in the midline of the forehead roughly at the glabella) and treated with electrical stimulation.</description>
          </group>
          <group group_id="O2">
            <title>Sham Acupuncture (SA)</title>
            <description>Needles placed laterally on the scalp, not corresponding to any traditional meridians. No electrical stimulation delivered.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Functioning and Health-related Quality of Life as Rated by the Medical Outcomes Survey-Version 1 (MOS-36) Physical Component Score (MOSPCS)</title>
          <description>Mean change in scores on the Medical Outcomes Survey-Version 1 (MOS-36) PHYSICAL Component Score (MOSPCS) from baseline to post-intervention across treatment group. Minimum Score = 0 (worse); Maximum Score = 100 (better), Normed to be at 50 on a control population. Positive Mean Change scores indicate improvement (an increase in scale score/better).</description>
          <population>ITT, excluding the first four sham acupuncture subjects, whom the primary acupuncturist erred in treating. Although he correctly used the sham electricity procedure, for these subjects he placed needles in the verum electroacupuncture points of GV-20 and Yin tang.</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.54" spread="6.92"/>
                    <measurement group_id="O2" value="-1.65" spread="7.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.32</p_value>
            <p_value_desc>Statistic (t): -1.00</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Functioning and Health-related Quality of Life as Rated by the Medical Outcomes Survey-Version 1 (MOS-36) Mental Component Score (MOSMCS)</title>
        <description>Mean change in scores on the Medical Outcomes Survey-Version 1 (MOS-36) Mental Component Score (MOSMCS) from baseline to post-intervention across treatment group. Minimum Score = 0 (worse); Maximum Score = 100 (better) , Normed to be at 50 on a control population. Positive Mean Change scores indicate improvement (an increase in scale score).</description>
        <time_frame>Mean Change from Baseline to Post-Intervention Endpoint</time_frame>
        <population>ITT, excluding the first four sham acupuncture subjects, whom the primary acupuncturist erred in treating. Although he correctly used the sham electricity procedure, for these subjects he placed needles in the verum electroacupuncture points of GV-20 and Yin tang.</population>
        <group_list>
          <group group_id="O1">
            <title>Electroacupuncture (EA)</title>
            <description>Needles placed at traditional meridian locations, GV-20 (on the crown of the head) and yin tang (in the midline of the forehead roughly at the glabella) and treated with electrical stimulation.</description>
          </group>
          <group group_id="O2">
            <title>Sham Acupuncture (SA)</title>
            <description>Needles placed laterally on the scalp, not corresponding to any traditional meridians. No electrical stimulation delivered.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Functioning and Health-related Quality of Life as Rated by the Medical Outcomes Survey-Version 1 (MOS-36) Mental Component Score (MOSMCS)</title>
          <description>Mean change in scores on the Medical Outcomes Survey-Version 1 (MOS-36) Mental Component Score (MOSMCS) from baseline to post-intervention across treatment group. Minimum Score = 0 (worse); Maximum Score = 100 (better) , Normed to be at 50 on a control population. Positive Mean Change scores indicate improvement (an increase in scale score).</description>
          <population>ITT, excluding the first four sham acupuncture subjects, whom the primary acupuncturist erred in treating. Although he correctly used the sham electricity procedure, for these subjects he placed needles in the verum electroacupuncture points of GV-20 and Yin tang.</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.23" spread="13.62"/>
                    <measurement group_id="O2" value="14.12" spread="17.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.09</p_value>
            <p_value_desc>Statistic (t): 1.56</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Functioning and Health-related Quality of Life as Rated by the Medical Outcomes Survey-Version 1 (MOS-36) Bodily Pain Index (MOSBPI)</title>
        <description>Mean change in scores on the Medical Outcomes Survey-Version 1 (MOS-36) Bodily Pain Index (MOSBPI) from baseline to post-intervention across treatment group. Minimum Score = 0 (more); Maximum Score = 100 (less). Positive Mean Change scores indicate improvement (an increase in scale score/less pain).</description>
        <time_frame>Mean Change from Baseline to Post-Intervention Endpoint</time_frame>
        <population>ITT, excluding the first four sham acupuncture subjects, whom the primary acupuncturist erred in treating. Although he correctly used the sham electricity procedure, for these subjects he placed needles in the verum electroacupuncture points of GV-20 and Yin tang.</population>
        <group_list>
          <group group_id="O1">
            <title>Electroacupuncture (EA)</title>
            <description>Needles placed at traditional meridian locations, GV-20 (on the crown of the head) and yin tang (in the midline of the forehead roughly at the glabella) and treated with electrical stimulation.</description>
          </group>
          <group group_id="O2">
            <title>Sham Acupuncture (SA)</title>
            <description>Needles placed laterally on the scalp, not corresponding to any traditional meridians. No electrical stimulation delivered.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Functioning and Health-related Quality of Life as Rated by the Medical Outcomes Survey-Version 1 (MOS-36) Bodily Pain Index (MOSBPI)</title>
          <description>Mean change in scores on the Medical Outcomes Survey-Version 1 (MOS-36) Bodily Pain Index (MOSBPI) from baseline to post-intervention across treatment group. Minimum Score = 0 (more); Maximum Score = 100 (less). Positive Mean Change scores indicate improvement (an increase in scale score/less pain).</description>
          <population>ITT, excluding the first four sham acupuncture subjects, whom the primary acupuncturist erred in treating. Although he correctly used the sham electricity procedure, for these subjects he placed needles in the verum electroacupuncture points of GV-20 and Yin tang.</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.04" spread="18.27"/>
                    <measurement group_id="O2" value="6.81" spread="19.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.17</p_value>
            <p_value_desc>Statistic (t): 1.40</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Weekly assessments from Baseline to Post-Intervention endpoint</time_frame>
      <desc>SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100</desc>
      <group_list>
        <group group_id="E1">
          <title>Electroacupuncture (EA)</title>
          <description>Needles placed at traditional meridian locations, GV-20 (on the crown of the head) and yin tang (in the midline of the forehead roughly at the glabella) and treated with electrical stimulation.</description>
        </group>
        <group group_id="E2">
          <title>Sham Acupuncture (SA)</title>
          <description>Needles placed laterally on the scalp, not corresponding to any traditional meridians. No electrical stimulation delivered.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="29"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>3</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="23" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="25" subjects_at_risk="29"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>PALPITATIONS / TACHYCARDIA</sub_title>
                <description>UKU Q29-PALPITATIONS / TACHYCARDIA: palpitation, feeling of rapid, strong and /or irregular heartbeats.</description>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="29"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>NAUSEA / VOMITING</sub_title>
                <description>UKU Q23-NAUSEA / VOMITING: to be recorded on the basis of the last 3 days.</description>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="29"/>
              </event>
              <event>
                <sub_title>DIARRHEA</sub_title>
                <description>UKU Q24-DIARRHEA: increased frequency and or thinner consistency of feces.</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="29"/>
              </event>
              <event>
                <sub_title>CONSTIPATION</sub_title>
                <description>UKU Q25-CONSTIPATION: reduced frequency of defection and/or thicker consistency of feces.</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="29"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>WEIGHT LOSS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="29"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>TREMOR</sub_title>
                <description>UKU Q15-TREMOR: this item comprises all forms of tremor.</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="29"/>
              </event>
              <event>
                <sub_title>PARATHESIAS</sub_title>
                <description>UKU Q18-PARATHESIAS: pricking, creeping, or burning sensations in the skin.</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="29"/>
              </event>
              <event>
                <sub_title>HEADACHE</sub_title>
                <description>UKU Q19-HEADACHE: on the scoring sheet headache is classified as (a) tension headache, (b) migraine, or (c) other forms of headache</description>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="29"/>
              </event>
              <event>
                <sub_title>ACCOMMODATION DISTURBANCES</sub_title>
                <description>UKU Q20-ACCOMMODATION DISTURBANCES: difficulty in seeing clearly or distinctly at close quarters (with or without glasses), whereas the patient sees clearly at a long distance (w/glasses if necessary)</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="29"/>
              </event>
              <event>
                <sub_title>ORTHOSTATIC DIZZINESS</sub_title>
                <description>UKU Q28-ORTHOSTATIC DIZZINESS: feeling of weakness, everything going black, buzzing in the ears, increasing tendency to faint when changing from supine or sitting position to upright position.</description>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="29"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>CONCENTRATION DIFFICULTIES</sub_title>
                <description>Udvalg Fur Kliniske Undersogesler (UKU) Question 1: CONCENTRATION DIFFICULTIES: difficulties in ability to concentrate, to collect one’s thoughts, or to sustain one’s attention.</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="29"/>
              </event>
              <event>
                <sub_title>ASTHENIA / LASSITUDE / INCREASED FATIGUABILITY</sub_title>
                <description>Udvalg Fur Kliniske Undersogesler (UKU) Question 2: ASTHENIA / LASSITUDE / INCREASED FATIGUABILITY: the patient’s experience of lassitude and lack of endurance. The assessment is based upon the patient’s reported statements.</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="29"/>
              </event>
              <event>
                <sub_title>SLEEPINESS / SEDATION</sub_title>
                <description>Udvalg Fur Kliniske Undersogesler (UKU) Question 3: SLEEPINESS / SEDATION: diminished ability to stay awake during the day. The assessment is based on clinical signs during the interview.</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="29"/>
              </event>
              <event>
                <sub_title>FAILING MEMORY</sub_title>
                <description>Udvalg Fur Kliniske Undersogesler (UKU) Q4-FAILING MEMORY: impaired memory. Assessment should be independent of any concentration difficulties.</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="29"/>
              </event>
              <event>
                <sub_title>TENSION / INNER UNREST</sub_title>
                <description>Udvalg Fur Kliniske Undersogesler (UKU) Q6-TENSION / INNER UNREST: inability to relax, nervous restlessness. This item is to be assessed on the basis of the patient’s experience and must be distinguished from motor akathesia (Q16).</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="29"/>
              </event>
              <event>
                <sub_title>INCREASED DURATION OF SLEEP:</sub_title>
                <description>Udvalg Fur Kliniske Undersogesler (UKU) Q7-INCREASED DURATION OF SLEEP: this should be assessed on the basis of the average of sleep over the three preceding nights. The assessment is to be made in relation to the patient’s usual pre-illness state.</description>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="29"/>
              </event>
              <event>
                <sub_title>REDUCED DURATION OF SLEEP:</sub_title>
                <description>Udvalg Fur Kliniske Undersogesler (UKU) Q8-REDUCED DURATION OF SLEEP: should be assessed on the basis of the average of sleep over the three preceding nights. The assessment is to be made in relation to the patient’s usual pre-illness state.</description>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="29"/>
              </event>
              <event>
                <sub_title>INCREASED DREAM ACTIVITY</sub_title>
                <description>Udvalg Fur Kliniske Undersogesler (UKU) Q9-INCREASED DREAM ACTIVITY: should be assessed independently of dream content and based on the average of sleep over the preceding nights in relation to the usual pre-illness dream activity.</description>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="29"/>
              </event>
              <event>
                <sub_title>EMOTIONAL INDIFFERENCE</sub_title>
                <description>Udvalg Fur Kliniske Undersogesler (UKU) Q10-EMOTIONAL INDIFFERENCE: a diminution of the patient’s empathy, leading to apathy.</description>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="29"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>MICTURITION DISTURBANCES</sub_title>
                <description>UKU Q26-MICTURITION DISTURBANCES: feeling of difficulty in starting and or resistance to micturition, weaker stream and/or increased time of micturition. Should be assessed on the basis of the last 3 days.</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="29"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>MENORRHAGIA</sub_title>
                <description>UKU Q37-(Menstruating females only) MENORRHAGIA: hypermenorrhea, polymenorrhea, or metrorrhagia during the last 3 months (or since last assessment).</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="29"/>
              </event>
              <event>
                <sub_title>DIMINISHED SEXUAL DESIRE</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="29"/>
              </event>
              <event>
                <sub_title>ERECTILE DYSFUNCTION</sub_title>
                <description>UKU Q43-(Sexually active males only) ERECTILE DYSFUNCTION: difficulty in attainting or maintaining an erection.</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="29"/>
              </event>
              <event>
                <sub_title>EJACULATORY DYSFUNCTION</sub_title>
                <description>UKU Q44-(Sexually active males only) EJACULATORY DYSFUNCTION: dysfunction of the patient’s ability to control ejaculation. Includes (a) premature or (b) delayed ejaculation.</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="29"/>
              </event>
              <event>
                <sub_title>ORGASMIC DYSFUNCTION</sub_title>
                <description>UKU Q45-(Sexually active females and males) ORGASMIC DYSFUNCTION: difficulty in obtaining and experiencing satisfactory orgasm.</description>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="29"/>
              </event>
              <event>
                <sub_title>DRY VAGINA</sub_title>
                <description>Q46-(Sexually active females only) DRY VAGINA: dryness of vagina with sexual stimulation.</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="29"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>INCREASED TENDENCY TO SWEATING</sub_title>
                <description>UKU Q30-INCREASED TENDENCY TO SWEATING: localized to the whole body, not only palms and soles of the foot.</description>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="29"/>
              </event>
              <event>
                <sub_title>RASH</sub_title>
                <description>UKU Q31-RASH: for scoring, the types of rashes are classified as (a) morbilliform, (b) petechial, (c) urticarial, (d) psoriataic, and (e) cannot be classified.</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="29"/>
              </event>
              <event>
                <sub_title>PRURITUS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="29"/>
              </event>
              <event>
                <sub_title>PHOTOSENSITIVITY</sub_title>
                <description>UKU Q33-PHOTOSENSITIVITY: increased sensitivity to sunlight.</description>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="29"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Four participants were excluded from the analyses because of a protocol violation. In the Sham Acupuncture group, the acupuncturist placed unelectrified needles in GV-20 and Yin tang points instead of placing them laterally.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Benoit H. Mulsant, MD</name_or_title>
      <organization>University of Pittsburgh</organization>
      <phone>(416) 535-8501 ext 3655</phone>
      <email>benoit_mulsant@camh.net</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

